<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26342975</PMID><DateCompleted><Year>2016</Year><Month>05</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1678-4391</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>5</Issue><PubDate><Year>2015</Year><Season>Sep-Oct</Season></PubDate></JournalIssue><Title>The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases</Title><ISOAbbreviation>Braz J Infect Dis</ISOAbbreviation></Journal><ArticleTitle>The role of microRNAs in enteroviral infections.</ArticleTitle><Pagination><StartPage>510</StartPage><EndPage>516</EndPage><MedlinePgn>510-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bjid.2015.06.011</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1413-8670(15)00135-X</ELocationID><Abstract><AbstractText>The genus Enterovirus, a member of the Picornavirus family, are RNA viruses that can cause poliomyelitis, hand-food-mouth disease, viral meningitis or meningoencephalitis, viral myocarditis and so on. MicroRNAs are a class of highly conserved, small noncoding RNAs recognized as important regulators of gene expression. Recent studies found that MicroRNAs play a significant role in the infection of Enterovirus, such as enterovirus 71, coxsackievirus B3 and other Enterovirus. Enteroviral infection can alter the expression of cellular MicroRNAs, and cellular MicroRNAs can modulate viral pathogenesis and replication by regulating the expression level of viral or host's genes. Herein, this review summarizes the role of MicroRNAs in enteroviral infection.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 Elsevier Editora Ltda. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Medicine, Jiangsu University, Zhenjiang, Jiangsu Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Zhenjiang Center for Disease Control and Prevention, Zhenjiang, Jiangsu Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jianguo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Zhenjiang First People's Hospital, Jiangsu Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Huaxi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Medicine, Jiangsu University, Zhenjiang, Jiangsu Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Lingxiang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Zhenjiang Center for Disease Control and Prevention, Zhenjiang, Jiangsu Province, China; School of Medicine, Jiangsu University, Zhenjiang, Jiangsu Province, China. Electronic address: maolingxiang@aliyun.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>09</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Braz J Infect Dis</MedlineTA><NlmUniqueID>9812937</NlmUniqueID><ISSNLinking>1413-8670</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010849" MajorTopicYN="N">Picornaviridae</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enterovirus</Keyword><Keyword MajorTopicYN="N">Infection</Keyword><Keyword MajorTopicYN="N">MicroRNAs</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>6</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>9</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26342975</ArticleId><ArticleId IdType="pmc">PMC9427576</ArticleId><ArticleId IdType="doi">10.1016/j.bjid.2015.06.011</ArticleId><ArticleId IdType="pii">S1413-8670(15)00135-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281&#x2013;297.</Citation><ArticleIdList><ArticleId IdType="pubmed">14744438</ArticleId></ArticleIdList></Reference><Reference><Citation>Lahmy R., Soleimani M., Sanati M.H., Behmanesh M., Kouhkan F., Mobarra N. MiRNA-375 promotes beta pancreatic differentiation in human induced pluripotent stem (hiPS) cells. Mol Biol Rep. 2014;41:2055&#x2013;2066.</Citation><ArticleIdList><ArticleId IdType="pubmed">24469711</ArticleId></ArticleIdList></Reference><Reference><Citation>Corthals S.L., Jongen-Lavrencic M., de Knegt Y., et al. Micro-RNA-15a and micro-RNA-16 expression and chromosome 13 deletions in multiple myeloma. Leuk Res. 2010;34:677&#x2013;681.</Citation><ArticleIdList><ArticleId IdType="pubmed">20031211</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L., Fan J., Belasco J.G. MicroRNAs direct rapid deadenylation of mRNA. Proc Natl Acad Sci U S A. 2006;103:4034&#x2013;4039.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1449641</ArticleId><ArticleId IdType="pubmed">16495412</ArticleId></ArticleIdList></Reference><Reference><Citation>Mourelatos Z., Dostie J., Paushkin S., et al. miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev. 2002;16:720&#x2013;728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC155365</ArticleId><ArticleId IdType="pubmed">11914277</ArticleId></ArticleIdList></Reference><Reference><Citation>Meister G., Tuschl T. Mechanisms of gene silencing by double-stranded RNA. Nature. 2004;431:343&#x2013;349.</Citation><ArticleIdList><ArticleId IdType="pubmed">15372041</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown B.D., Gentner B., Cantore A., et al. Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat Biotechnol. 2007;25:1457&#x2013;1467.</Citation><ArticleIdList><ArticleId IdType="pubmed">18026085</ArticleId></ArticleIdList></Reference><Reference><Citation>Westerhout E.M., Ooms M., Vink M., Das A.T., Berkhout B. HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res. 2005;33:796&#x2013;804.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC548362</ArticleId><ArticleId IdType="pubmed">15687388</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu S., Jin L., Zhang F., Sarnow P., Kay M.A. Biological basis for restriction of microRNA targets to the 3&#x2032; untranslated region in mammalian mRNAs. Nat Struct Mol Biol. 2009;16:144&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2713750</ArticleId><ArticleId IdType="pubmed">19182800</ArticleId></ArticleIdList></Reference><Reference><Citation>Doench J.G., Sharp P.A. Specificity of microRNA target selection in translational repression. Genes Dev. 2004;18:504&#x2013;511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC374233</ArticleId><ArticleId IdType="pubmed">15014042</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts A.P., Lewis A.P., Jopling C.L. miR-122 activates hepatitis C virus translation by a specialized mechanism requiring particular RNA components. Nucleic Acids Res. 2011;39:7716&#x2013;7729.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3177192</ArticleId><ArticleId IdType="pubmed">21653556</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay Y., Zhang J., Thomson A.M., et al. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature. 2008;455:1124&#x2013;1128.</Citation><ArticleIdList><ArticleId IdType="pubmed">18806776</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobert O. Gene regulation by transcription factors and microRNAs. Science. 2008;319:1785&#x2013;1786.</Citation><ArticleIdList><ArticleId IdType="pubmed">18369135</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3794896</ArticleId><ArticleId IdType="pubmed">19167326</ArticleId></ArticleIdList></Reference><Reference><Citation>Cullen B.R. Viral and cellular messenger RNA targets of viral microRNAs. Nature. 2009;457:421&#x2013;425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3074184</ArticleId><ArticleId IdType="pubmed">19158788</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla G.C., Singh J., Barik S. MicroRNAs: processing, maturation, target recognition and regulatory functions. Mol Cell Pharmacol. 2011;3:83&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3315687</ArticleId><ArticleId IdType="pubmed">22468167</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste M.S., Maher K., Kilpatrick D.R., Pallansch M.A. Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol. 1999;73:1941&#x2013;1948.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC104435</ArticleId><ArticleId IdType="pubmed">9971773</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., He Y., Yang H., et al. Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China. J Clin Microbiol. 2005;43:3835&#x2013;3839.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1233905</ArticleId><ArticleId IdType="pubmed">16081920</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y.F., Chou C.T., Lei H.Y., et al. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol. 2004;78:7916&#x2013;7924.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC446098</ArticleId><ArticleId IdType="pubmed">15254164</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong K.T., Munisamy B., Ong K.C., et al. The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways. J Neuropathol Exp Neurol. 2008;67:162&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pubmed">18219253</ArticleId></ArticleIdList></Reference><Reference><Citation>Knowlton K.U. CVB infection and mechanisms of viral cardiomyopathy. Curr Top Microbiol Immunol. 2008;323:315&#x2013;335.</Citation><ArticleIdList><ArticleId IdType="pubmed">18357777</ArticleId></ArticleIdList></Reference><Reference><Citation>Yajima T., Knowlton K.U. Viral myocarditis: from the perspective of the virus. Circulation. 2009;119:2615&#x2013;2624.</Citation><ArticleIdList><ArticleId IdType="pubmed">19451363</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarmiento L., Frisk G., Anagandula M., Cabrera-Rode E., Roivainen M., Cilio C.M. Expression of innate immunity genes and damage of primary human pancreatic islets by epidemic strains of echovirus: implication for post-virus islet autoimmunity. PLoS ONE. 2013;8:e77850.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3815302</ArticleId><ArticleId IdType="pubmed">24223733</ArticleId></ArticleIdList></Reference><Reference><Citation>Takamatsu Y., Uchida L., Nga P.T., et al. An approach for differentiating echovirus 30 and Japanese encephalitis virus infections in acute meningitis/encephalitis: a retrospective study of 103 cases in Vietnam. Virol J. 2013;10:280. DCOM-20140623.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3847169</ArticleId><ArticleId IdType="pubmed">24025733</ArticleId></ArticleIdList></Reference><Reference><Citation>Yarmolskaya M.S., Shumilina E.Y., Ivanova O.E., Drexler J.F., Lukashev A.N. Molecular epidemiology of echoviruses 11 and 30 in Russia: different properties of genotypes within an enterovirus serotype. Infect Genet Evol. 2015;30:244&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pubmed">25562123</ArticleId></ArticleIdList></Reference><Reference><Citation>Persu A., Baicus A., Stavri S., Stavri S., Combiescu M., Combiescu M. Non-polio enteroviruses associated with acute flaccid paralysis (AFP) and facial paralysis (FP) cases in Romania, 2001&#x2013;2008. Roum Arch Microbiol Immunol. 2009;68:20&#x2013;26. DCOM-20090708.</Citation><ArticleIdList><ArticleId IdType="pubmed">19507623</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y., Wei X., Tang C., et al. Circulating microRNA-101 as a potential biomarker for hepatitis B virus-related hepatocellular carcinoma. Oncol Lett. 2013;6:1811&#x2013;1815.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3834113</ArticleId><ArticleId IdType="pubmed">24260081</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T., Zhang J., Cui M., et al. Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis. Neoplasia. 2013;15:1282&#x2013;1291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3858896</ArticleId><ArticleId IdType="pubmed">24339740</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahluwalia J.K., Khan S.Z., Soni K., et al. Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology. 2008;5:117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2635386</ArticleId><ArticleId IdType="pubmed">19102781</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung T.L., Rice A.P. miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1. PLoS Pathog. 2009;5:e1000263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2607557</ArticleId><ArticleId IdType="pubmed">19148268</ArticleId></ArticleIdList></Reference><Reference><Citation>Jopling C.L., Schutz S., Sarnow P. Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. Cell Host Microbe. 2008;4:77&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3519368</ArticleId><ArticleId IdType="pubmed">18621012</ArticleId></ArticleIdList></Reference><Reference><Citation>Niepmann M. Activation of hepatitis C virus translation by a liver-specific microRNA. Cell Cycle. 2009;8:1473&#x2013;1477.</Citation><ArticleIdList><ArticleId IdType="pubmed">19372740</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimakami T., Yamane D., Welsch C., Hensley L., Jangra R.K., Lemon S.M. Base pairing between hepatitis C virus RNA and microRNA 122 3&#x2032; of its seed sequence is essential for genome stabilization and production of infectious virus. J Virol. 2012;86:7372&#x2013;7383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3416334</ArticleId><ArticleId IdType="pubmed">22532678</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui Y.L., Tan T.L., Woo W.H., et al. Enterovirus71 (EV71) utilise host microRNAs to mediate host immune system enhancing survival during infection. PLoS ONE. 2014;9:e102997.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4105423</ArticleId><ArticleId IdType="pubmed">25047717</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui L., Guo X., Qi Y., et al. Identification of microRNAs involved in the host response to enterovirus 71 infection by a deep sequencing approach. J Biomed Biotechnol. 2010;2010:425939.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2896697</ArticleId><ArticleId IdType="pubmed">20625495</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui L., Qi Y., Li H., et al. Serum microRNA expression profile distinguishes enterovirus 71 and coxsackievirus 16 infections in patients with hand-foot-and-mouth disease. PLoS ONE. 2011;6:e27071. DCOM-20120518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3210764</ArticleId><ArticleId IdType="pubmed">22087245</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z., Ke X., Wang M., et al. Human microRNA hsa-miR-296-5p suppresses enterovirus 71 replication by targeting the viral genome. J Virol. 2013;87:5645&#x2013;5656.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3648165</ArticleId><ArticleId IdType="pubmed">23468506</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen B.P., Dai H.J., Yang Y.H., Zhuang Y., Sheng R. MicroRNA-23b inhibits enterovirus 71 replication through downregulation of EV71 VPl protein. Intervirology. 2013;56:195&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pubmed">23594713</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z., Tien P. MiR373 and miR542-5p regulate the replication of enterovirus 71 in rhabdomyosarcoma cells. Sheng Wu Gong Cheng Xue Bao. 2014;30:943&#x2013;953.</Citation><ArticleIdList><ArticleId IdType="pubmed">25212011</ArticleId></ArticleIdList></Reference><Reference><Citation>Mihm S. Activation of type I and type III interferons in chronic hepatitis C. J Innate Immun. 2015;7:251&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6738759</ArticleId><ArticleId IdType="pubmed">25766746</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Xie J., Xu X., et al. MicroRNA-548 down-regulates host antiviral response via direct targeting of IFN-lambda1. Protein Cell. 2013;4:130&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4875363</ArticleId><ArticleId IdType="pubmed">23150165</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho B.C., Yu I.S., Lu L.F., et al. Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type I interferon. Nat Commun. 2014;5:3344.</Citation><ArticleIdList><ArticleId IdType="pubmed">24561744</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu C., He X., Zheng Z., et al. Downregulation of microRNA miR-526a by enterovirus inhibits RIG-I-dependent innate immune response. J Virol. 2014;88:11356&#x2013;11368. doi: 10.1128/JVI.01400-01414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01400-01414</ArticleId><ArticleId IdType="pmc">PMC4178780</ArticleId><ArticleId IdType="pubmed">25056901</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y.L., Ho B.C., Sher S., Yu S.L., Yang P.C. miR-146a and miR-370 coordinate enterovirus 71-induced cell apoptosis through targeting SOS1 and GADD45beta. Cell Microbiol. 2014;3</Citation><ArticleIdList><ArticleId IdType="pubmed">25469565</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho B.C., Yu S.L., Chen J.J., et al. Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E. Cell Host Microbe. 2011;9:58&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">21238947</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Chen X., Shi Y., et al. miR-27a suppresses EV71 replication by directly targeting EGFR. Virus Genes. 2014;49:373&#x2013;382.</Citation><ArticleIdList><ArticleId IdType="pubmed">25212431</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L.J., Jiang T., Zhao W., et al. Parallel mRNA and microRNA profiling of HEV71-infected human neuroblastoma cells reveal the up-regulation of miR-1246 in association with DLG3 repression. PLoS ONE. 2014;9:e95272.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3989279</ArticleId><ArticleId IdType="pubmed">24739954</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Xiao Z., He F., Zou J., Wu S., Liu Z. MicroRNAs regulate the pathogenesis of CVB3-induced viral myocarditis. Intervirology. 2013;56:104&#x2013;113.</Citation><ArticleIdList><ArticleId IdType="pubmed">23183417</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Qin Y., Tong L., et al. MiR-342-5p suppresses coxsackievirus B3 biosynthesis by targeting the 2C-coding region. Antiviral Res. 2012;93:270&#x2013;279.</Citation><ArticleIdList><ArticleId IdType="pubmed">22197249</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong L., Lin L., Wu S., et al. MiR-10a* up-regulates coxsackievirus B3 biosynthesis by targeting the 3D-coding sequence. Nucleic Acids Res. 2013;41:3760&#x2013;3771.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3616696</ArticleId><ArticleId IdType="pubmed">23389951</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemida M.G., Ye X., Zhang H.M., et al. MicroRNA-203 enhances coxsackievirus B3 replication through targeting zinc finger protein-148. Cell Mol Life Sci. 2013;70:277&#x2013;291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11113921</ArticleId><ArticleId IdType="pubmed">22842794</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez A., Vigorito E., Clare S., et al. Requirement of bic/microRNA-155 for normal immune function. Science. 2007;316:608&#x2013;611.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2610435</ArticleId><ArticleId IdType="pubmed">17463290</ArticleId></ArticleIdList></Reference><Reference><Citation>Corsten M.F., Papageorgiou A., Verhesen W., et al. MicroRNA profiling identifies microRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis. Circ Res. 2012;111:415&#x2013;425.</Citation><ArticleIdList><ArticleId IdType="pubmed">22715471</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connell R.M., Taganov K.D., Boldin M.P., Cheng G., Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA. 2007;104:1604&#x2013;1609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1780072</ArticleId><ArticleId IdType="pubmed">17242365</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye X., Hemida M.G., Qiu Y., Hanson P.J., Zhang H.M., Yang D. MiR-126 promotes coxsackievirus replication by mediating cross-talk of ERK1/2 and Wnt/beta-catenin signal pathways. Cell Mol Life Sci. 2013;70:4631&#x2013;4644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11113642</ArticleId><ArticleId IdType="pubmed">23811937</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H.F., Ding Y.J., Shen Y.-W., et al. MicroRNA-1 represses Cx43 expression in viral myocarditis. Mol Cell Biochem. 2012;362:141&#x2013;148.</Citation><ArticleIdList><ArticleId IdType="pubmed">22045061</ArticleId></ArticleIdList></Reference><Reference><Citation>He J., Yue Y., Dong C., Xiong S. MiR-21 confers resistance against CVB3-induced myocarditis by inhibiting PDCD4-mediated apoptosis. Clin Invest Med. 2013;36:E103&#x2013;E111.</Citation><ArticleIdList><ArticleId IdType="pubmed">23544605</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.L., Wu W., Xue Y., et al. MicroRNA-21 and -146b are involved in the pathogenesis of murine viral myocarditis by regulating TH-17 differentiation. Arch Virol. 2013;158:1953&#x2013;1963.</Citation><ArticleIdList><ArticleId IdType="pubmed">23588407</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye X., Zhang H.M., Qiu Y., et al. Coxsackievirus-induced miR-21 disrupts cardiomyocyte interactions via the downregulation of intercalated disk components. PLoS Pathog. 2014;10:e1004070. DCOM-20141210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3983067</ArticleId><ArticleId IdType="pubmed">24722419</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H.F., Ding Y.J., Zhang Z.X., et al. MicroRNA21 regulation of the progression of viral myocarditis to dilated cardiomyopathy. Mol Med Rep. 2014;10:161&#x2013;168. DCOM-20150113.</Citation><ArticleIdList><ArticleId IdType="pubmed">24804616</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi B., Kim H.A., Suh C.H., Byun H.O., Jung J.Y., Sohn S. The relevance of miRNA-21 in HSV-induced inflammation in a mouse model. Int J Mol Sci. 2015;16:7413&#x2013;7427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4425025</ArticleId><ArticleId IdType="pubmed">25849652</ArticleId></ArticleIdList></Reference><Reference><Citation>Damania P., Sen B., Dar S.B., et al. Hepatitis B virus induces cell proliferation via HBx-induced microRNA-21 in hepatocellular carcinoma by targeting programmed cell death protein4 (PDCD4) and phosphatase and tensin homologue (PTEN) PLoS ONE. 2014;9:e91745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3954734</ArticleId><ArticleId IdType="pubmed">24633222</ArticleId></ArticleIdList></Reference><Reference><Citation>Bondanese V.P., Francisco-Garcia A., Bedke N., Davies D.E., Sanchez-Elsner T. Identification of host miRNAs that may limit human rhinovirus replication. World J Biol Chem. 2014;5:437&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4243148</ArticleId><ArticleId IdType="pubmed">25426267</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouda R., Onomoto K., Takahasi K., et al. Retinoic acid-inducible gene I-inducible miR-23b inhibits infections by minor group rhinoviruses through down-regulation of the very low density lipoprotein receptor. J Biol Chem. 2011;286:26210&#x2013;26219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3138319</ArticleId><ArticleId IdType="pubmed">21642441</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayed A.S., Xia K., Salma U., Yang T., Peng J. Diagnosis, prognosis and therapeutic role of circulating miRNAs in cardiovascular diseases. Heart Lung Circ. 2014;16</Citation><ArticleIdList><ArticleId IdType="pubmed">24726001</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Liu Y., Granberg K.J., et al. Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma. Oncogene. 2014;21</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4205227</ArticleId><ArticleId IdType="pubmed">24747968</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi Y., Zhu Z., Shi Z., et al. Dysregulated microRNA expression in serum of non-vaccinated children with varicella. Viruses. 2014;6:1823&#x2013;1836.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4014722</ArticleId><ArticleId IdType="pubmed">24759212</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek J., Kang S., Min H. MicroRNA-targeting therapeutics for hepatitis C. Arch Pharm Res. 2014;37:299&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pubmed">24385319</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>